Submitted by Anonymous (not verified) on 22 November 2024 - 13:18
Opinion/decision on a Paediatric investigation plan (PIP): Veyvondi, vonicog alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology, PIP number: P/0416/2023
Source:
